News X Close Refine your results Search here results search-total-matching103search-total-matching Scientists reveal variability as key mechanism behind adaptability of immune cells | UCL Cancer Institute - UCL - London's Global University HRH The Duke of Kent visits UCL Cancer Institute | UCL Cancer Institute - UCL - London's Global University New non-invasive test to detect bladder cancer developed | UCL Cancer Institute - UCL - London's Global University Landmark study provides insight into chemotherapy treatment for lung cancer patients | UCL Cancer Institute - UCL - London's Global University New funding for UCL cancer centres announced | UCL Cancer Institute - UCL - London's Global University Light therapy set to transform prostate cancer treatment | UCL Cancer Institute - UCL - London's Global University New research leads the way in epigenomic studies | UCL Cancer Institute - UCL - London's Global University Powerful analysis tool for epigenomic studies developed | UCL Cancer Institute - UCL - London's Global University BLUEPRINT celebrates major manuscript release | UCL Cancer Institute - UCL - London's Global University UCL spin-outs at heart of new £1 billion life sciences investment group | UCL Cancer Institute - UCL - London's Global University 1234567891011 Please enable JavaScript to use this page or visit this page for a non javascript version.
X Close Refine your results Search here results search-total-matching103search-total-matching Scientists reveal variability as key mechanism behind adaptability of immune cells | UCL Cancer Institute - UCL - London's Global University HRH The Duke of Kent visits UCL Cancer Institute | UCL Cancer Institute - UCL - London's Global University New non-invasive test to detect bladder cancer developed | UCL Cancer Institute - UCL - London's Global University Landmark study provides insight into chemotherapy treatment for lung cancer patients | UCL Cancer Institute - UCL - London's Global University New funding for UCL cancer centres announced | UCL Cancer Institute - UCL - London's Global University Light therapy set to transform prostate cancer treatment | UCL Cancer Institute - UCL - London's Global University New research leads the way in epigenomic studies | UCL Cancer Institute - UCL - London's Global University Powerful analysis tool for epigenomic studies developed | UCL Cancer Institute - UCL - London's Global University BLUEPRINT celebrates major manuscript release | UCL Cancer Institute - UCL - London's Global University UCL spin-outs at heart of new £1 billion life sciences investment group | UCL Cancer Institute - UCL - London's Global University 1234567891011 Please enable JavaScript to use this page or visit this page for a non javascript version.
Close
